Quantum
Home > Boards > US OTC > Medical - Healthcare >

BioCorRx (BICX)

BICX RSS Feed
Add BICX Price Alert      Hide Sticky   Hide Intro
Moderator: Pip611, Swisher27
Search This Board: 
Last Post: 11/14/2018 1:04:05 PM - Followers: 143 - Board type: Free - Posts Today: 0

 

 

About BioCorRx

Program Overview

BioCorRx (OTCBB: BICX) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.

The program consists of two components:BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates.BioCorRx also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.

Technology

Naltrexone is a medication that blocks the effects of drugs known as opioids and was approved by the FDA in 1995 for the treatment of alcohol dependence.

Learn more about the side effects of naltrexone.

Naltrexone blocks the parts of the brain that "feel pleasure” when patients use alcohol. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol and even if alcohol is used, the effects of it will be extremely limited - making sobriety the only option. Once medical intervention has reduced the physical need for alcohol, the program goes on to address the patient's psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.

naltrexone implant

While other companies use naltrexone in their treatments, the drug is typically administered in oral or injection form, requiring their patients to be responsible for taking the medication or scheduling an appointment.

While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.

The outpatient naltrexone implant procedure can take as little as 20 minutes under local anesthetic in some cases. Most patients can return to work or their daily routine in the same day, without the cravings for alcohol.

Mission, Vision, Values

Mission

BioCorRx is focused on providing leadership and innovation for the treatment of alcoholism by offering a high-quality, comprehensive and cost-effective recovery program that allows patients and their loved ones to celebrate freedom from the cycle of alcohol addiction. Our program is built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering alcoholics.

Vision

BioCorRx strives to be the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, as well as their family and friends. By providing patients a "Fresh Start" on life, they have the opportunity to live happier, healthier, more productive lives away from the damaging impact of alcohol. We have built an organization that is committed to nurturing research for cutting-edge alcohol recovery technologies and integrating those technologies with comprehensive alcohol recovery treatment programs.

Values

BioCorRx provides the opportunity and tools to treatment centers so they can help patients live happier, healthier, and more productive lives to those suffering from alcohol addiction (as well as their family and friends) by helping them break the addiction cycle and live alcohol-free. We want patients to celebrate freedom from the past and hope for the future. Our team consists of physicians, coaches, founders and management that are committed to providing high-quality services and adherence to ethical care.

Our goal is to give our treatment center partners the ability to deliver our program in a timely, warm and compassionate way to give patients, as well as their families and friends, peace of mind. To achieve this, BioCorRx has built its program around highly-qualified alcohol addiction specialists and effective treatment solutions.

We are committed to quality and continuous improvement in order to meet our partners’ needs for an individualized program dedicated to alcohol addiction recovery.

Investors Overview

BioCorRx is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.

More than 7% of the US population ages 18 years and older or 13.8 million Americans have problems with drinking, including 8.1 million people who suffer from alcoholism. And the costs financially are staggering. Alcohol dependency and abuse costs the US over $220 billion a year. For the sake of comparison, this is greater than the amount of money spent to combat cancer ($196 billion) and obesity ($133 billion).

BioCorRx intends to distribute the program to a new clinic in the United States every 60 to 90 days. Clinics using our program are also holding discussions with major health insurance providers to pay for all or a portion of the treatment fees.

Business Model

BioCorRx’s research has discovered that demand for its services are high and that growth in highly marketed segments of the population may be achieved through partnering with additional clinic sites. The company is also exploring the sub-licensing of the program to select regions of the US and internationally.

BioCorRx's goal is to meet its growth targets through licensing opportunities by promoting its naltrexone implant product and counseling service model to existing medical clinics and treatment centers that will purchase the program and/or product from the company. In addition, Fresh Start Private intends to open corporately owned clinics in select key markets where it is deemed appropriate.

Stock Price & Charts

BioCorRx is a fully reporting company. Financial reports and other reports are available for view or by visiting the OTCBB.com online website. Audited financial reports are available quarterly.

Company Structure Details

  • Legal name: BioCorRx
    Sector: Healthcare
    Industry: Specialized Health Services
    Full Time Employees: 4
    Public Company: SEC Reporting and fully audited
    Symbol: BICX
    Exchange: OTCBB
    Outstanding: 117,800,000
    Authorized: 200,000,000
    CUSIP: 35804J102
    NAICS Code: 623220
    SIC Number: 8093
    Transfer Agent: Columbia Stock Transfer Company, 1869 E. Seltice Way #292, Post Falls, ID 83854 Tel (208) 664-3544
    CIK: 0001443863
    EIN: 26-1972677
    Year End: December 31
    State of incorporation: Nevada
    Products: Alcohol rehabilitation, exclusive naltrexone implant technology
    Address: 601 North Parkcenter Drive, Suite 103, Santa Ana, CA 92705 USA
    Investors: 858-381-4677
    Email: investors@biocorrx.com
    Website: www.biocorrx.com
Watch Jeremy Miller on Fox News!
https://www.youtube.com/watch?v=kVKgWi3_t5Y

<iframe width="560" height="315" src="; frameborder="0" allowfullscreen></iframe>www.youtube.com/embed/xhJrYqsV0VQ

<iframe width="560" height="315" src="https://www.youtube.com/watch?v=kVKgWi3_t5Y" frameborder="0" allowfullscreen></iframe>


 

BICX Chart

Key Executives

Kent Emry - CEO, Director
Brady Granier -COO, Director
Lourdes Felix -CFO, Director
Dr. Jorge Andrade, Jr. - Director
Neil Muller -Co-Founder and President, Director 

Locations
Locations of independently owned clinics using our Fresh Start Program

Start Fresh Recovery
720 N. Tustin Ave.
Suite 206
Santa Ana, CA 92705
714-541-6100
800-916-1099
www.startfreshrecovery.com 
www.stopdrinkingUSA.com

Start Fresh Executive Recovery
367 E Virginia Ave
Phoenix, AZ 85004
855-393-HOPE (4673)
www.ExecutiveRecovery.net 

Fresh Start Private Florida
1415 Panther Lane
Suites 313-320
Naples, FL 34109
800-985-7574
www.FreshStartPrivateFlorida.com 

Start Fresh Alcohol Recovery Center
2827 S. 88th St
Omaha NE 68124
402-884-1221
www.startfreshNE.com

Coming Soon!

• San Francisco, California
• Chandler, Arizona
• North Scottsdale, Arizona
• Connecticut

Insider Interview Links

December 2, 2013 - thewallstreetanalyzer.com Interview with Brady Granier COO
November 14, 2013 - SmallCapVoice Interview with Kent Emry CEO
October 2, 2013 - SmallCapVoice Interview with Brady Granier COO

 

 

Quantum
BICX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#7544  Sticky Note VIVITROL is injectable naltrexone produced by Alkermes plc Pip611 09/09/16 05:15:47 PM
#11716   The pessimist in me fears that these “updates msw1221 11/14/18 01:04:05 PM
#11715   Who do you think is selling? Certain people Kizersosae 11/09/18 07:50:05 PM
#11714   No regrets because I made money on this Fido 11/09/18 02:26:09 PM
#11713   What does it feel like when you sell RBC- 11/09/18 12:07:46 PM
#11712   https://ir.biocorrx.com/sec-filings-email/content/0001477932-18-005350/bicx_ex99 thejourneyman 11/09/18 06:23:52 AM
#11711   Looking at the previous round of awards, they GaryWinthorpe 11/08/18 11:24:40 AM
#11710   What's the date for the release? big orange 11/07/18 09:32:41 PM
#11709   Y’all are going to want to be buying Joshthebeast24 11/07/18 11:50:30 AM
#11708   The slow bleed. Admtiger 11/06/18 10:06:24 AM
#11707   lol. At least we have someplace to sleep stanggt 11/06/18 09:33:03 AM
#11706   I'm still watching? That's a positive.... :):):) Fido 11/06/18 09:09:27 AM
#11705   I for ONE with double that prediction PERIOD! drugmanrx 11/05/18 10:15:34 PM
#11704   Hmmm......lets see, oh yeah. Ok, I am rocky1088 11/05/18 08:49:12 PM
#11703   Somebody say something positive before I jump out stanggt 11/05/18 02:46:38 PM
#11702   Waiting for the grant news in November via GaryWinthorpe 10/30/18 11:50:46 AM
#11701   Awfully quiet around here. stanggt 10/30/18 11:16:42 AM
#11700   So to uplist to $5 would mean around Admtiger 10/24/18 11:01:51 PM
#11699   He comes the run back to .15 - Pip611 10/24/18 01:17:45 PM
#11696   8:10 mark in the interview Brady talks about RBC- 10/23/18 01:48:13 PM
#11695   If it can hold .10 to .20 my drugmanrx 10/23/18 11:40:43 AM
#11694   Just bought more shares on the dip. NIDA Pip611 10/23/18 11:40:42 AM
#11693   Probably 250 to 1. Evidently is pps got big orange 10/23/18 11:28:55 AM
#11692   7:45 mark "Up listing to NASDAQ very drugmanrx 10/23/18 11:03:53 AM
#11691   Kizer, must be getting down to your purchase msw1221 10/23/18 10:55:39 AM
#11690   Update: https://ir.biocorrx.com/press-releases/detail/142 GaryWinthorpe 10/23/18 09:57:13 AM
#11689   Please see NR from 2 weeks ago. Swisher27 10/23/18 09:16:06 AM
#11688   Never got the grant. Probably have to big orange 10/22/18 06:25:17 PM
#11687   What in tarnations is going on GaryWinthorpe 10/22/18 02:28:16 PM
#11686   Answers for questions in order asked: 1)I don’t think Kizersosae 10/19/18 06:03:12 PM
#11685   Just because you’re input might not be what Leshrac528 10/19/18 04:52:09 PM
#11684   Thanks for the kind words, but I am Kizersosae 10/19/18 02:30:22 PM
#11683   Kizer, Regardless of your level of investment, you have Leshrac528 10/19/18 01:14:29 PM
#11682   Hey Alkermes! Did ya see that? Nice move Brady. thejourneyman 10/19/18 11:33:03 AM
#11681   Excellent news on many levels. Jon Boyz 10/19/18 08:23:16 AM
#11680   You were reading my mind lol Joshthebeast24 10/18/18 01:31:09 AM
#11675   I hold no position in this stock. It Swisher27 10/17/18 08:19:44 AM
#11673   I’ve been following BioCorRx for awhile. I’m a StockGurus1 10/17/18 05:01:15 AM
#11672   Big buy at the close, maybe tomorrow is JB51 10/16/18 07:51:52 PM
#11671   I think it’s a last ditch effort by Joshthebeast24 10/16/18 03:33:41 PM
#11670   Down on big volume, thoughts? msw1221 10/16/18 03:26:09 PM
#11669   Took mine out over weekend. So much fun stanggt 10/16/18 08:07:36 AM
#11668   Yep, and my '69 sits in the garage. Fido 10/11/18 01:50:39 PM
#11667   Yup. No money....no sp increase. stanggt 10/11/18 11:05:02 AM
#11666   Hey Kiz, here's my thoughts: SHOW ME THE Fido 10/10/18 09:23:54 AM
#11665   Has VDM-001 even started phase 1 studies? big orange 10/09/18 05:06:20 PM
#11664   Busy morning for me so I didn’t have CowboySurfer 10/09/18 10:54:21 AM
#11663   I’m not gonna give my thoughts, because I’m Kizersosae 10/09/18 09:53:51 AM
#11662   https://globenewswire.com/news-release/2018/10/05/1617352/0/en/BioCorRx-to-Exhib CowboySurfer 10/08/18 02:41:05 PM
#11661   https://globenewswire.com/news-release/2018/10/05/1617352/0/en/BioCorRx-to-Exhib CowboySurfer 10/08/18 02:39:26 PM
#11660   BioCorRx &TRUMP @International Association of Chiefs of Police CowboySurfer 10/08/18 02:20:50 PM
PostSubject